by Bruce Sylvester: Patients treated for one year with evolocumab, an investigative drug used to lower LDL cholesterol, have achieved significant reductions in mortality, heart attack and stroke,… read more.
by Bruce Sylvester: The addition of antiplatelet drug ticagrelor to aspirin for long-term post-heart attack therapy has reduced the rate of mortality from subsequent cardiovascular causes, heart attack… read more.
by Bruce Sylvester: Treatment with the growth hormone growth factor-1 (IGF-1) significantly improves social impairment associated with autism spectrum disorder (ASD) in patients with a related genetic syndrome,… read more.
by Bruce Sylvester: Results from a French pilot study suggest that gallopamil effectively reduces symptoms in severe asthma. The findings appeared on January 28, 2015 in the American Journal… read more.
by Bruce Sylvester: Ranibizumab (Lucentis®) therapy appears to have efficacy in reversing diabetes-related vision loss in some populations, researchers reported online on Feb. 19 in the journal Opthalmology.
by Bruce Sylvester – Even just a few years of hormone replacement therapy (HRT) appears to significantly increase the risk of two forms of ovarian cancer, researchers reported… read more.
by Bruce Sylvester: Lenvatinib treatment has resulted in significant improvement in progression-free survival among patients with advanced radioiodine-refractory thyroid cancer, researchers from a Phase III trial reported in… read more.
by Bruce Sylvester: Vitamin D supplementation appears to lower the incidence of COPD (chronic obstructive pulmonary disease) lung disease flare-up by over 40% in patients with a vitamin… read more.
by Bruce Sylvester: Post-surgical nonsteroidal anti-inflammatory drug (NSAID) therapy appears to entail an increased risk of anastomotic leak at the surgical junction among patients who have undergone non-elective… read more.
by Bruce Sylvester: About 12 percent of patients treated with aspirin for cardiovascular disease prevention are receiving aspirin inappropriately, researchers reported on Jan, 12, 2015 in the Journal… read more.
by Bruce Sylvester: Patients with metastatic melanoma treated with dual sargramostim/ipilimumab rather than ipilimumab alone have achieved longer overall survival and lower toxicity, but no difference in progression-free… read more.
by Bruce Sylvester: Onset of diabetes raises the risk of significant memory and cognitive problems during the following 20 years researchers reported in the Dec. 2 issue of… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
